Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ying‑Liang Wu

VHL Loss Predicts Response to Aurora Kinase a Inhibitor in Renal Cell Carcinoma Cells

Molecular Medicine Reports

Molecular Biology

Cancer Research

Molecular Medicine

English

Related publications

-Catenin Links Von Hippel-Lindau to Aurora Kinase a and Loss of Primary Cilia in Renal Cell Carcinoma

Journal of the American Society of Nephrology : JASN

English

MYC Activation Cooperates With VHL and Ink4a/Arf Loss to Induce Clear Cell Renal Cell Carcinoma

Nature Communications

Molecular Biology

English

Insights Into Epigenetic Remodeling in VHL-Deficient Clear Cell Renal Cell Carcinoma

Cancer Discovery

English

The VHL-HIF Signaling in Renal Cell Carcinoma: Promises and Pitfalls

English

High Expression of FER Tyrosine Kinase Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma

Oncology Letters

Cancer Research

English

The Role of VHL in Clear-Cell Renal Cell Carcinoma and Its Relation to Targeted Therapy

Kidney International

English

Clinical Benefit to an Aurora a Kinase Inhibitor in a Patient With Metastatic Integrase Interactor 1‐Deficient Carcinoma

Cancer Research

English

Inactivation of the PBRM1 Tumor Suppressor Gene Amplifies the HIF-response in VHL−/−clear Cell Renal Carcinoma

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

The Aurora-Kinase a Phe31-Ile Polymorphism as Possible Predictor of Response to Treatment in Head and Neck Squamous Cell Carcinoma

English